Testosterone Therapy Does Not Raise Prostate Cancer Recurrence Risk
After radical prostatectomy, men who received testosterone therapy for hypogonadism had a lower rate of biochemical recurrence than nonhypogonadal men.
Diagnosis & Disease Information
Study: Testosterone Therapy Takes off Pounds
BMI and waist circumference declined in hypogonadal men treated with parenteral testosterone undecanoate.
Prostate Cancer Risk Not Higher with TRT Use
Researchers studied 850 testosterone-deficient men who received 1,000 mg parenteral testosterone undecanoate six weeks after baseline and then every 12 weeks for up to five years.
Prostate Cancer Risk Not Elevated with Testosterone Replacement
In fact, men on testosterone replacement therapy (TRT) had a lower PCa rate than men not on TRT.
LUTS Not Worsened by Testosterone Replacement
Many men even experience an improvement in lower urinary tract symptoms.
Elderly Men Benefit from TRT, Study Finds
Hypogonadal men aged 65 years and older experience significant benefit from TRT over 12 months.
Low Testosterone Linked to Long-Acting Opioids
California researchers have found that low testosterone levels occur five times more often among men taking long-acting opioids.
Minimal Priapism Risk with AndroGel 1% Use
Researchers reviewed clinical trial and postmarketing data.
Low Testosterone Increases Risk of Mortality, Anemia, Reduced ESA Response
Testosterone deficiency is common in many patients with CKD, but the treatment of this deficiency and associated side effects have not always received much attention.
Testosterone Deficiency To Have Big Public Health Impact
Researchers predict about 1.3 million new cases of cardiovascular disease related to low testosterone over a 20-year period.
- Loading...
Loading...
Next post in Hypogonadism
Loading... 
Loading...